Y. Lei et al. / Dyes and Pigments 133 (2016) 261e272
263
2.2. Synthesis of compounds 6aꢀc
67.7, 59.0, 49.4, 40.1, 31.7, 29.6, 29.1, 29.0, 26.5, 22.5, 14.8, 14.0. FT-IR
(KBr, cmꢀ1): 2914, 2852, 2174, 1657, 1586, 1525, 1471, 1363, 1329,
1279, 1187, 1168, 1057, 966, 808, 740. MS (ESI, m/z): 593.30 (MþþH).
Anal. Calcd for C38H48N4O2: C, 76.99; H, 8.16; N, 9.45. Found: C,
76.90; H, 8.22; N, 9.35.
2-(2,6-Bis((E)-4-(dimethylamino)styryl)-1-octylpyridin-4(1H)-
ylidene)-1H-indene-1,3(2H)- dione (DHP-3). Orange solids
(450 mg), 72% yield; m. p. 237e238 ꢁC. 1H NMR (CDCl3, 500 MHz):
A mixture of compound 5a/5b/5c (5 mmol) and 1-octylamine
(10 mL) in acetonitrile (15 mL) was heated under argon at 80 ꢁC
for 24 h. The reaction mixture was allowed to reach room tem-
perature and then poured into ice methanol, a large amount of
solids separated out in the mixture. After filtration, the crude
product was washed with methanol three times, and then dried to
afford pure compounds 6a¡c.
d
9.00 (s, 2H), 7.60 (dd, 3J ¼ 4.5 Hz, 4J ¼ 3.0 Hz, 2H), 7.46 (dd,
2-(2,6-Dimethyl-1-octylpyridin-4(1H)-ylidene)malononitrile
(6a). White solids (1.06 g), 75% yield; m. p. 154e155 ꢁC. 1H NMR
3J ¼ 4.5 Hz, 4J ¼ 3.0 Hz, 2H), 7.39 (d, J ¼ 8.5 Hz, 4H), 7.31 (d,
J ¼ 15.5 Hz, 2H), 6.72 (d, J ¼ 15.5 Hz, 2H), 6.66 (d, J ¼ 8.5 Hz, 4H),
4.08 (t, J ¼ 8.0 Hz, 2H), 3.00 (s, 12H), 1.83e1.78 (m, 2H), 1.38e1.24
(CDCl3, 500 MHz):
d
6.58 (s, 2H), 3.90 (t, J ¼ 8.5 Hz, 2H), 2.46 (s, 6H),
1.71e1.65 (m, 2H), 1.39e1.26 (m, 10H), 0.87 (t, J ¼ 7.0 Hz, 3H). 13
C
(m, 10H), 0.86 (t, J ¼ 7.0 Hz, 3H). 13C NMR (CDCl3, 125 MHz):
d 192.7,
NMR (CDCl3, 125 MHz):
d
155.7, 147.5, 147.4, 118.7, 113.8, 49.1, 44.7,
151.3, 149.4,149.2, 140.5,139.6,131.4, 128.9,123.5,119.6,113.9,113.7,
112.0, 102.7, 49.8, 40.1, 31.7, 29.4, 29.1, 29.0, 26.5, 22.6, 14.1. MS (ESI,
m/z): 626.30 (MþþH). FT-IR (KBr, cmꢀ1): 2923, 1710, 1625, 1600,
1580, 1524, 1489, 1393, 1329, 1185, 1092, 980, 948. Anal. Calcd for
44.6, 31.6, 29.6, 29.0, 28.9, 26.6, 22.5, 20.5, 13.9. MS (ESI, m/z):
284.10 (MþþH). FT-IR (KBr, cmꢀ1): 2926, 2192, 2171, 1625, 1550,
1506, 1483, 1352, 1317, 1185, 1062, 874, 725.
Ethyl 2-cyano-2-(2,6-dimethyl-1-octylpyridin-4(1H)-ylidene)-
C42H47N3O2: C, 80.60; H, 7.57; N, 6.71. Found: C, 80.73; H, 7.48; N,
6.59.
acetate (6b). White solids (1.29 g), 78% yield; m. p. 105e106 ꢁC. 1H
NMR (CDCl3, 500 MHz):
d
8.14 (d, J ¼ 2.5 Hz, 1H), 6.75 (d, J ¼ 2.0 Hz,
1H), 4.17 (q, J ¼ 7.0 Hz, 2H), 3.86 (t, J ¼ 7.0 Hz, 2H), 2.43 (s, 3H), 2.41
(s, 3H), 1.67e1.61 (m, 2H), 1.38e1.24 (m, 13H), 0.87 (t, J ¼ 7.0 Hz,
2.4. Synthesis of the AIE nanoparticles based on DHP-1ꢀDHP-3
3H). 13C NMR (CDCl3, 125 MHz):
d 167.5, 154.4, 146.6, 146.4, 122.1,
A
THF solution (6 mL) containing DHP-1/DHP-2/DHP-3
(0.06 mg) and DSPE-PEG2000 (0.12 mg) was stirred at room tem-
perature for 30 min. Then the solution was purified with a 0.22
116.0, 114.9, 67.8, 59.1, 48.9, 31.6, 29.8, 29.0, 28.9, 26.6, 22.5, 20.7,
20.3, 14.7, 14.0. MS (ESI, m/z): 331.15 (MþþH). FT-IR (KBr, cmꢀ1):
2927, 2180, 1666, 1627, 1501, 1354, 1260, 1120, 1062, 857, 764.
2-(2,6-Dimethyl-1-octylpyridin-4(1H)-ylidene)-1H-indene-
1,3(2H)-dione (6c). Yellow solids (1.49 g), 82% yield; m. p.
mm
syringe filter. A 2 mL quantity of the above solution was injected
rapidly into 8 mL Milli-Q Water under sonication. The dilute AIE
nanoparticle suspension was obtained after THF evaporation under
reduced pressure. The AIE nanoparticle suspension was further
concentrated to 2 mL and filtered with a syringe filter (0.22
obtain the AIE nanoparticles based on DHP-1ꢀDHP-3.
219e220 ꢁC. 1H NMR (CDCl3, 500 MHz):
d 8.50 (s, 2H), 7.59e7.58 (m,
2H), 7.46e7.45 (m, 2H), 3.72 (t, J ¼ 8.5 Hz, 2H), 2.46 (s, 6H),
1.59e1.53 (m, 2H), 1.25e1.20 (m, 10H), 0.87 (t, J ¼ 7.0 Hz, 3H). 13
C
mm) to
NMR (CDCl3, 125 MHz):
d 192.7, 149.5, 148.3, 140.1, 131.7, 119.8,
116.9, 101.9, 49.3, 31.6, 29.3, 29.0, 28.7, 26.5, 22.5, 20.6,14.0. MS (ESI,
m/z): 364.15 (MþþH). FT-IR (KBr, cmꢀ1): 2925, 2369, 1713, 1616,
1578, 1507, 1359, 1341, 1188, 1096, 952, 885, 738.
2.5. Cell culture
MCF-7 cells were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM) containing 10% fetal bovine serum (FBS) and anti-
2.3. Synthesis of DHP derivatives
biotics (100 units/mL penicillin and 100
mg/mL streptomycin),
A solution of compound 6a/6b/6c (1.0 mmol), 4-(dimethyla-
mino)benzaldehyde (1.49 g, 10.0 mmol), piperidine (1 mL) and
DMSO (7 mL) was refluxed under argon for 48 h. After cooling to
room temperature, the reaction mixture was poured into methanol
(50 mL) and suction filtered to give the crude product. The crude
product was washed with methanol three times, respectively, and
then dried to give the pure DHP derivatives.
maintained at 37 ꢁC under a humidified atmosphere of 95% air and
5% CO2. The cells were pre-cultured prior to experiments until 90%
confluence was reached.
2.6. Cytotoxicity evaluation
2-(2,6-Bis((E)-4-(dimethylamino)styryl)-1-octylpyridin-4(1H)-
ylidene)-malononitrile (DHP-1). Orange solids (371 mg), 68% yield;
The cytotoxicity of the AIE nanoparticles based on DHP-1ꢀDHP-
3 against MCF-7 cells was estimated using MTT assays, respectively.
MCF-7 cells were seeded in 96-well plates at a density of
4 ꢂ 104 cells mLꢀ1. After 24 h incubation, the medium was replaced
by the AIE nanoparticles at concentrations of 0.08, 0.12, 0.24, 0.3,
0.4, 0.6, and 1.2 ppm and cultured at 37 ꢁC for additional 48 h. The
sample wells were washed twice with 1 ꢂ PBS (Phosphate buffer
m. p. 231e232 ꢁC. 1H NMR (CDCl3, 500 MHz):
d
7.38 (d, J ¼ 8.5 Hz,
4H), 7.12 (d, J ¼ 15.5 Hz, 2H), 6.91 (s, 2H), 6.70e6.65 (m, 6H), 4.02 (t,
J ¼ 8.0 Hz, 2H), 3.03 (s, 12H), 1.84e1.78 (m, 2H), 1.40e1.27 (m, 10H),
0.87 (t, J ¼ 7.0 Hz, 3H). 13C NMR (CDCl3, 125 MHz):
d 155.3, 151.5,
148.7, 139.7, 129.0, 122.9, 119.6, 113.2, 112.0, 110.4, 49.6, 44.9, 40.1,
31.7, 29.5, 29.1, 29.0, 26.4, 22.5, 14.0. MS (ESI, m/z): 546.30 (MþþH).
FT-IR (KBr, cmꢀ1): 2931, 2360, 2187, 1588, 1532, 1507, 1491, 1473,
1329, 1178, 963, 818, 753. Anal. Calcd for C36H43N5: C, 79.23; H,
7.94; N, 12.83. Found: C, 79.34; H, 7.85; N, 12.65.
saline) and 100 mL of freshly prepared MTT (0.5 mg/mL) solution in
culture medium was added into each well. The MTT medium so-
lution was removed after 3 h incubation. Freshly prepared DMSO
(150 mL) was then added into each well and the plate was gently
Ethyl 2-(2,6-bis((E)-4-(dimethylamino)styryl)-1-octylpyridin-
4(1H)- ylidene)-2-cyanoacetate (DHP-2). Orange solids (414 mg),
shaken for 10 min at room temperature to dissolve all the pre-
cipitates formed. The absorbance of individual wells at 570 nm was
then monitored by the microplate Reader (BioTek, PowerWave XS2,
Vermont, USA). The absorbance of MTT in the sample well was
determined by the differentiation between the absorbance of the
sample well and that of the corresponding control well. Cell
viability was expressed by the ratio of the absorbance of MTT in the
sample wells to that of the cells incubated with culture medium
only.
70% yield; m. p. 181e182 ꢁC. 1H NMR (CDCl3, 500 MHz):
d 8.56 (d,
J ¼ 2.5 Hz, 1H), 7.37 (d, J ¼ 7.5 Hz, 4H), 7.22 (d, J ¼ 15.5 Hz, 1H), 7.14
(d, J ¼ 2.5 Hz, 1H), 7.12 (d, J ¼ 15.5 Hz, 1H), 6.70e6.66 (m, 6H), 4.22
(q, J ¼ 7.0 Hz, 2H), 4.01 (t, J ¼ 8.0 Hz, 2H), 3.014 (s, 6H), 3.011 (s, 6H),
1.82e1.76 (m, 2H), 1.36e1.25 (m, 13H), 0.87 (t, J ¼ 7.0 Hz, 3H). 13
C
NMR (CDCl3,125 MHz): d 167.9,154.0,151.3,151.2,148.2,148.1,139.1,
139.0, 128.8, 123.4, 123.2, 122.8, 114.2, 113.9, 112.8, 112.1, 112.0, 111.8,